The potentiating effect of naloxone upon apomorphine-induced hyperthermia.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D001831:Body Temperature / Q000187:drug effects*; D003533:Cyproheptadine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D004357:Drug Synergism; D010134:Fenclonine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D009270:Naloxone / Q000494:pharmacology*; D011817:Rabbits
D003533:Cyproheptadine; D009270:Naloxone; D008238:Lysergic Acid Diethylamide; D006220:Haloperidol; D001058:Apomorphine; D010134:Fenclonine; D003913:Dextroamphetamine